Exchange transfusion before cardiopulmonary bypass in sickle cell disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 20609818.
- Also identified by DOI 10.1016/j.athoracsur.2009.08.037.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cardiac operations in patients with sickle cell disease present the surgical team with many challenges. We describe a method of complete intraoperative exchange transfusion in the operating room that reduces the hemoglobin S (Hb S) level to less than 5%, without preoperative exchange transfusions. Plasma and platelet fractions separated intraoperatively from the patient's native red cell mass were used, in addition to hemoconcentration while on cardiopulmonary bypass, to effectively reduce the red cell and clotting factor transfusion requirements after the procedure. The technique is useful in reducing transfusion requirements, avoiding cardiovascular stress associated with exchange transfusion before the operation, and can be used in urgent situations.
Medical subject headings
- Anemia, Sickle Cell
- Cardiopulmonary Bypass
- Exchange Transfusion, Whole Blood
- Mitral Valve Insufficiency